Neurodevelopment in Children Exposed In Utero to Dolutegravir- or Efavirenz-Based ART in Botswana
Background: Dolutegravir (DTG)- and, to a lesser extent, efavirenz (EFV)- based antiretroviral treatment (ART) regimens are commonly used by pregnant persons living with HIV in high burden HIV settings, increasingly with initiation prior to conception. Little is known about the impact of in utero exposure to DTG- or EFV-based ART on child neurodevelopmental (ND) outcomes,…